|
|
| MRD / Regn No. |
: THBC\23-24\09410 |
Date |
: 07/07/2026 |
| Patient Name |
: Fuaad Shaikh |
Age & Gender |
: 44 Yrs. / Male |
| Contact No. |
: 9819871878 |
UHID |
: |
| Ht / Wt / BMI |
: 177 / 89.95 / 28.71 |
BP S / BP D |
: 118 / 83 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
HYPOTHYROIDISM (07/Feb/2026) | |
|
Subjective |
: |
WT STABLE,F/H- DM- GRANDMOTHER,HYPOTHYROIDISM FEB 26,MEDS STARTED SINCE 10 DAYS |
|
Objective |
: |
JUN-2026 REPORTS,FBS-88,ALT-24/ AST-20,URIC ACID-8.8,TC-198/ TG-147/ LDL-123/ HDL-46,HB-14.5/ HBA1C-6.0%,FT3-3.59/FT4-1.38/ TSH-9.15,VITB12-518.3,FEB-2026 REPORTS,FBS-74,ALT-18/ AST-16,URIC ACID-7.4,TC-206/ TG-125/ LDL-131/ HDL-50,HB-13.1/ HBA1C-5.9%,FT3-3.07/ FT4-1.25/ TSH-23.06,VITB12-530.7 |
|
Plan |
: |
CAN CONSIDER RETESTING TOTAL T3 / T4 / TSH AND THYROID PEROXIDASE ANTIBODY - IF TSH> 10 OR THERE IS IMPACT ON BP OR CHOL - THEN CONSIDER MEDS |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
FOLITRAX 15MG |
ORAL |
0-0-1 |
AD/ SAT-ONCE A WEEK
|
2 MTHS |
|
|
2 |
TFCT-NIB 5MG |
ORAL |
1-0-1 |
ABF/ AD
|
2 MTHS |
|
|
3 |
FOLVITE 5 MG |
ORAL |
0-0-1 |
ABF
|
2 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 07/Sep/2026 |
| Tests Suggested For Next Visit |
: TOTAL T3 / T4 / TSH / THYROID PEROXIDASE ANTIBODY > 2 MTHS |
| |
|
| |
|
|
